anxiety disorder

临床试验

计划入组 24 人 · 首次发布于 2013 年 12 月 3 日

已完成

NCT02083926

Ketamine Infusion for Social Anxiety Disorder

计划入组 18 人 · 首次发布于 2014 年 3 月 11 日

已完成

NCT00515242

Therapeutic Massage for Generalized Anxiety Disorder

计划入组 68 人 · 首次发布于 2007 年 8 月 13 日

药物

查看全部 319 →

Small Molecule

Approved

Thioridazine

生产企业：Novartis pharmaceuticals corp, Actavis mid atlantic llc，另有 15 家

Sertraline(Zoloft)

相关疾病：Binge Eating Disorder (BED), Bulimia Nervosa，另有 7 项

C₁₇H₁₇Cl₂N · Rx

Small Molecule

Approved

Duloxetine(Cymbalta, Drizalma, Irenka, Yentreve, Duloxetine Zentiva, Duloxetine Mylan, Duloxetine Lilly, Duloxetine Viatris (previously Duloxetine Mylan))

生产企业：Eli lilly and co

相关疾病：Chronic Lower Back Pain (CLBP), Chronic Musculoskeletal Pain，另有 6 项

C₁₈H₁₉NOS · Rx

机构

查看全部 19 →

VistaGen Therapeutics

United States

MOOD AND ANXIETY RESEARCH, INC.

United States

THE PARKINSON'S AND MOVEMENT DISORDER INSTITUTE

United States

资讯

查看全部 3927 →

去年

Vistagen Initiates Phase 2 Repeat Dose Study of Fasedienol for Social Anxiety Disorder

10个月前

Neuphoria Therapeutics Advances BNC-210 Phase 3 Trial for Social Anxiety Disorder

去年

临床试验

Vilazodone for Separation Anxiety Disorder

Ketamine Infusion for Social Anxiety Disorder

Therapeutic Massage for Generalized Anxiety Disorder

药物

Thioridazine

Sertraline(Zoloft)

Duloxetine(Cymbalta, Drizalma, Irenka, Yentreve, Duloxetine Zentiva, Duloxetine Mylan, Duloxetine Lilly, Duloxetine Viatris (previously Duloxetine Mylan))

机构

VistaGen Therapeutics

MOOD AND ANXIETY RESEARCH, INC.

THE PARKINSON'S AND MOVEMENT DISORDER INSTITUTE

资讯

Vistagen Initiates Phase 2 Repeat Dose Study of Fasedienol for Social Anxiety Disorder

Neuphoria Therapeutics Advances BNC-210 Phase 3 Trial for Social Anxiety Disorder

Neuphoria Therapeutics Completes Phase 3 Enrollment for BNC-210 Social Anxiety Disorder Treatment